Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs

Journal of Immunological Methods

Volumn 409, Issue , 2014, Pages 99-106

  Garcia, Ambrosia ^a   Keinonen, Sarah ^a   Sanchez, Ana M ^a   Ferrari, Guido ^a,b   Denny, Thomas N ^a,b   Moody, M Anthony ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Leukapheresis; Leukocytes; PBMC; Proficiency testing

Indexed keywords

ARTICLE; CLINICAL LABORATORY; CRYOPRESERVATION; GOOD LABORATORY PRACTICE; HUMAN; LEUKAPHERESIS; LEUKOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; VALIDATION PROCESS;

LEUKAPHERESIS; LEUKOCYTES; PBMC; PROFICIENCY TESTING;

CELL SURVIVAL; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; CRYOPRESERVATION; GUIDELINE ADHERENCE; HIV INFECTIONS; HIV-1; HUMANS; LABORATORY PROFICIENCY TESTING; LEUKAPHERESIS; LEUKOCYTES, MONONUCLEAR; MONITORING, IMMUNOLOGIC; OBSERVER VARIATION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; QUALITY CONTROL; QUALITY INDICATORS, HEALTH CARE; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TIME FACTORS; TRANSPORTATION; WORKFLOW;

EID: 84906097983     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.05.019     Document Type: Article

References (7)

1. AABB, Standards Program Committee Standards for blood banks and transfusion services 2012, American Association of Blood Banks, Bethesda, MD. 28th ed.
2. Bull M., Lee D., Stucky J., Chiu Y.-L., Rubin A., Horton H., McElrath M.J. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immunol. Methods 2007, 322:57.
3. Crosley L.K., Duthie S.J., Polley A.C., Bouwman F.G., Heim C., Mulholland F., Horgan G., Johnson I.T., Mariman E.C., Elliott R.M., Daniel H., de Roos B. Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics. Genes Nutr. 2009, 4:95.
4. Ganzel C., Becker J., Mintz P.D., Lazarus H.M., Rowe J.M. Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012, 26:117.
5. Graw R.G., Herzig G.P., Eisel R.J., Perry S. Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion 1971, 11:94.
6. Sarzotti-Kelsoe M., Cox J., Cleland N., Denny T., Hural J., Needham L., Ozaki D., Rodriguez-Chavez I.R., Stevens G., Stiles T., Tarragona-Fiol T., Simkins A. Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials. Plos Med. 2009, 6:e1000067.
7. Weinberg A., Song L.-Y., Wilkening C.L., Fenton T., Hural J., Louzao R., Ferrari G., Etter P.E., Berrong M., Canniff J.D., Carter D., Defawe O.D., Garcia A., Garrelts T.L., Gelman R., Lambrecht L.K., Pahwa S., Pilakka-Kanthikeel S., Shugarts D.L., Tustin N.B. Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays. J Immunol Meth 2010, 363:42.